LakeShore Biopharma Co (LakeShore Biopharma Co) Total Stockholders Equity : $76.34 Mil (As of Sep. 2023)

View and export this data going back to 2023. Start your Free Trial

What is LakeShore Biopharma Co Total Stockholders Equity?

LakeShore Biopharma Co's Total Stockholders Equity for the quarter that ended in Sep. 2023 was $76.34 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. LakeShore Biopharma Co's Book Value per Share for the quarter that ended in Sep. 2023 was $0.82. The ratio of a company's debt over equity can be used to measure how leveraged this company is. LakeShore Biopharma Co's Debt-to-Equity for the quarter that ended in Sep. 2023 was 0.99.

LakeShore Biopharma Co Total Stockholders Equity Historical Data

The historical data trend for LakeShore Biopharma Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LakeShore Biopharma Co Total Stockholders Equity Chart

LakeShore Biopharma Co Annual Data

Trend

Mar21

Mar22

Mar23

Total Stockholders Equity

-78.16

-110.17

105.71

LakeShore Biopharma Co Semi-Annual Data
	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Total Stockholders Equity	Get a 7-Day Free Trial			-	-110.17	-135.44	105.71	76.34

LakeShore Biopharma Co (NAS:LSB) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

LakeShore Biopharma Co's Book Value per Share for the quarter that ended in Sep. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(76.336	-	0)	/	93.0582
	=	0.82

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

LakeShore Biopharma Co's Debt-to-Equity for the quarter that ended in Sep. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(25.729	+	50.21)	/	76.336
	=	0.99

LakeShore Biopharma Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of LakeShore Biopharma Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

LakeShore Biopharma Co (LakeShore Biopharma Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LakeShore Biopharma Co Ltd (NAS:LSB) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

H6Z:Germany

Address

38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629

Website

https://www.yishengbio.com

YS Biopharma Co Ltd is principally engaged in the research, development, manufacturing and sale of vaccines and therapeutic biologics. It developed a PIKA immunomodulating technology platform and a series of product candidates targeting rabies, hepatitis B, influenza and other indications. It is also conducting the production and sale of YSJA, a rabies vaccine, the first aluminium-free lyophilized rabies vaccine that was launched in China. It has one operating segment, which is the development, production, marketing and sale of biopharmaceutical products.